Valneva SE American Depositary Shares VALN
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $15.50 (+122.7% upside)
Key Stats
- Today's Range
- $6.71 – $7.06
- 50-Day Range
- $4.75 – $7.31
- 52-Week Range
- $4.75 – $12.25
- Volume
- 22K shs
- Average Volume
- 134K shs
- Market Cap
- $646.70 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.02%
- Days to Cover
- 1.00
About Valneva SE American Depositary Shares
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Related Stocks
Compare head-to-head: VALN vs NVDA·VALN vs AAPL·VALN vs GOOGL·VALN vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.